| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting Fees | 5,150 | 5,150 |
| Category | Amount |
|---|---|
| NONE |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific Corp | 2006-04 | P | 2024-10 |
Sold |
25,043 | 6,554 | fmv | 18,489 | ||
| FIRST TRUST INTERMEDIATE DURATION PFD & INCOME | 2013-05 | P | 2024-04 |
Sold |
2,965 | 3,840 | fmv | -875 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| SHS First Trust | 37,587 | 27,360 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 5858 SHS Boston Scientific Corp | 132,391 | 523,237 |
| 299 SHS Corteva Inc | 0 | 17,031 |
| 124 SHS Dow Inc | 4,158 | 4,976 |
| 469 SHS Elanco Animal Health Inc | 6,712 | 5,680 |
| SHS Intl Flavor & Fragrances | 0 | 0 |
| 1,156 SHS Eli Lilly & Co | 0 | 892,432 |
| 675 SHS Eli Lilly & Co | 612 | 521,100 |
| 10,250 SHS Eli Lilly & Co | 9,289 | 7,913,000 |
| 1,081 SHS Eli Lilly & Co | 123,828 | 834,532 |
| 835 SHS Eli Lilly & Co | 493,059 | 644,620 |
| 451 SHS Elanco Animal Health Inc | 6,454 | 5,461 |
| Description | Amount |
|---|---|
| Adjustment of Contribution to Cost Basis | 8,152,581 |
| Description | Amount |
|---|---|
| Cost Basis Adjustment- Grants Paid | 87,864 |